Neurocrine Biosciences
(NASDAQ) NBIX
Neurocrine Biosciences Financials at a Glance
Market Cap
$16.70B
Revenue (TTM)
$3.10B
Net Income (TTM)
$668.60M
EPS (TTM)
$6.50
P/E Ratio
25.53
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$164.42
Volume
9,031
Open
$166.28
Price
$164.42
Volume
9,031
Open
$166.28
Previous Close
$166.06
Daily Range
$164.41 - $168.05
52-Week Range
$122.14 - $169.57
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$164.42
Volume
9,031
Open
$166.28
Previous Close
$166.06
Daily Range
$164.41 - $168.05
52-Week Range
$122.14 - $169.57
Estimated Earnings Date
Jul 29, 2026
NBIX News
NBIX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Neurocrine Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
2,000
CEO
Kyle W. Gano, PhD, MBA
Website
www.neurocrine.comHeadquarters
San Diego, CA 92130, US
NBIX Financials
Key Financial Metrics (TTM)
Gross Margin
98.17%
Operating Margin
25.19%
Net Income Margin
21.55%
Return on Equity
21.64%
Return on Capital
16.88%
Return on Assets
13.63%
Earnings Yield
3.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$16.70B
Shares Outstanding
100.55M
Volume
9.03K
Avg. Volume
1.20M
Financials (TTM)
Gross Profit
$3.05B
Operating Income
$781.50M
EBITDA
$955.80M
Operating Cash Flow
$863.70M
Capital Expenditure
-$32.40M
Free Cash Flow
$831.30M
Cash & ST Invst.
$1.32B
Total Debt
$406.20M
Neurocrine Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$814.50M
+42.2%
Gross Profit
$800.70M
+42.1%
Gross Margin
98.31%
N/A
Market Cap
$16.70B
N/A
Market Cap/Employee
$9.28M
N/A
Employees
1,800
N/A
Net Income
$197.90M
+2405.1%
EBITDA
$254.10M
+711.8%
Quarterly Fundamentals
Total Cash
$1.32B
+39.5%
Total Debt
$406.20M
-9.2%
Accounts Receivable
$768.10M
+48.9%
Inventory
$64.50M
+9.1%
Long Term Debt
$406.20M
-9.2%
Short Term Debt
$0.00
N/A
Return on Assets
13.63%
N/A
Return on Invested Capital
19.18%
N/A
Free Cash Flow
$136.70M
+152.7%
Operating Cash Flow
$145.80M
+125.0%